The aldose reductase inhibitor epalrestat exerts nephritic protection on diabetic nephropathy in db/db mice through metabolic modulation-Reference-Cited by-同舟云学术

The aldose reductase inhibitor epalrestat exerts nephritic protection on diabetic nephropathy in db/db mice through metabolic modulation

Published:2018-06-21 Issue:1 Volume:40 Page:86-97
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

He Jun,Gao Hao-xue,Yang Na,Zhu Xiao-dong,Sun Run-bin,Xie Yuan,Zeng Cai-hong,Zhang Jing-wei,Wang Jian-kun,Ding Fei,Aa Ji-ye,Wang Guang-ji

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.nature.com/articles/s41401-018-0043-5.pdf

Reference67 articles.

1. Oates PJ. Aldose reductase inhibitors and diabetic kidney disease. Curr Opin Investig Drugs. 2010;11:402–17.

2. Nishikawa T, Edelstein D, Brownlee M. The missing link: a single unifying mechanism for diabetic complications. Kidney Int Suppl. 2000;77:S26–30.

3. Hers HG. Le mécanisme de la transformation de glucose en fructose par les vésicules séminales. Biochim Biophys Acta. 1956;22:202–3.

4. Dunlop M. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int Suppl. 2000;77:S3–12.

5. Yabe-Nishimura C. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol Rev. 1998;50:21–34.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolomics and molecular dynamics unveil the therapeutic potential of epalrestat in diabetic nephropathy;International Immunopharmacology;2024-10

2. Inhibitory Impact of Quercetin Nanoparticles on Polyol Pathway in Hyperthyroidism Rats;BioNanoScience;2024-04-02

3. Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies;Bioorganic Chemistry;2024-04

4. An aldose reductase inhibitor, WJ-39, ameliorates renal tubular injury in diabetic nephropathy by activating PINK1/Parkin signaling;European Journal of Pharmacology;2024-03

5. Parallelism and non-parallelism in diabetic nephropathy and diabetic retinopathy;Frontiers in Endocrinology;2024-02-14